The director of the Center for the Coordination of Health Alerts and Emergencies (CCAES), Fernando Simón, has considered that every time there is a “Stronger” evidence for vaccine efficacy AstraZeneca in those over 65, with which it is probable that “in a very short time” Spain will approve its administration for this group.
Simón has assured this at the press conference every Monday in which he gives an account of the evolution of the coronavirus pandemic in Spain: today he recalled that the technical sheet of the AstraZeneca vaccine “does not close the door” to which it is can be used in those over 65.
Last week, the Public Health Commission gave the green light to the fifth update of the vaccination strategy against covid in Spain, which included the extension of the age of use of the AstraZeneca vaccine to 65 years.
Clinical trials of the drug did not include people over 65 years of age, with which, Simón recalled, it was not known if it would be effective in them or not, but now there is more information about it, after several countries have vaccinated all age groups with the serum, and everything indicates that the efficacy is similar to that of the population that participated in the trials.
“Every time the evidence is more solid”, has insisted the director of the CCAES and, therefore, “it is very likely that in a very short time” this vaccine can be proposed for those over 65 years of age, although it will be necessary to see what who decides the presentation of vaccines, “who are those who know about this issue.”
Simón has insisted that he does not know if it will be this week, the next week or something later, but the evidence that the vaccine might be effective in those over 65 is “growing.”
Regarding the rate of vaccination in the country, Simón has said that “Spain is vaccinating very well” and has trusted that, if the rate of arrival of vaccines is not delayed, the target of 70% of the vaccinated population can be reached around the summer.
He also recalled that the infrastructure of the National Health System (SNS) has allowed during the flu vaccination campaign to administer 14 million doses in seven weeks without “great efforts”, with which for the covid the system can absorb “significantly more” than two million weekly doses inoculated.
Asked about the law that came into force last week that requires the use of the mask even when the safety distance of 1.5 meters can be maintained, the director of the CCAES has expressed the opinion that he believes that it will be corrected or discussed in the next days.
The Minister of Health, Carolina Darias, has already offered the communities to work “in a technical way” to review and update this part of the norm.
In fact, Simón has assured that within the SNS Interterritorial Council the matter is already being discussed and “probably” the minister will bring a proposal in the next meeting with the councilors, because it is “common sense”.
Simón has also referred to the British variant, of which he has said that “it is already our variant”, because it is the majority, with which he has advocated for ceasing to give it an “excessive weight” and thinking “very carefully” in the others, which are marginal and could have an impact, such as the Brazilian and the South African: “They are the two that interest us the most,” added the director of CCAES.
He also indicated that the British is not giving way to the other two, which could affect the effectiveness of vaccines, which is something “that could be helping us.”
Eddie is an Australian news reporter with over 9 years in the industry and has published on Forbes and tech crunch.